Diagnostic Ability of Maximum Blink Interval Together with Japanese Version of Ocular Surface Disease Index Score for Dry Eye Disease

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 23

PMID 33093551

Citations 14

Authors

Kunihiko Hirosawa

Takenori Inomata

Jaemyoung Sung

Masahiro Nakamura

Yuichi Okumura

Akie Midorikawa-Inomata

Maria Miura

Kenta Fujio

Yasutsugu Akasaki

Keiichi Fujimoto

Jun Zhu

Atsuko Eguchi

Ken Nagino

Mizu Kuwahara

Hurramhon Shokirova

Ai Yanagawa

Akira Murakami

Affiliations

Soon will be listed here.

Abstract

Various symptoms of the dry eye disease (DED) interfere with the quality of life and reduce work productivity. Therefore, screening, prevention, and treatment of DED are important. We aimed to investigate the potential diagnostic ability of the maximum blink interval (MBI) (the length of time participants could keep their eyes open) with disease-specific questionnaire for DED. This cross-sectional study included 365 patients (252 with DED and 113 without DED) recruited between September 2017 and December 2019. Discriminant validity was assessed by comparing the non-DED and DED groups based on the MBI with a Japanese version of the Ocular Surface Disease Index (J-OSDI) and tear film breakup time (TFBUT) with J-OSDI classifications. The MBI with J-OSDI showed good discriminant validity by known-group comparisons. The positive and predictive values of MBI with J-OSDI were 96.0% (190/198 individuals) and 37.1% (62/167 individuals), respectively. The area under the receiver operating characteristic curve (AUC) of MBI with J-OSDI was 0.938 (95% confidence interval 0.904-0.971), the sensitivity was 75.4% (190/252 individuals), and the specificity was 92.9% (105/113 individuals), which are similar to the diagnostic ability of TFBUT with J-OSDI (AUC 0.954). In conclusion, MBI with J-OSDI may be a simple, non-invasive screening test for DED.

Citing Articles

Ocular Surface Disease Index questionnaire in different languages.

Aljarousha M, Alghamdi W, Attaallah S, Alhoot M Med Hypothesis Discov Innov Ophthalmol. 2025; 13(4):190-200.

PMID: 40065803 PMC: 11890261. DOI: 10.51329/mehdiophthal1510.

Influence of Lifestyle Factors on Ocular Surface Parameters in Relation to Age.

Garcia-Queiruga J, Pena-Verdeal H, Sabucedo-Villamarin B, Noya-Padin V, Giraldez M, Yebra-Pimentel E Life (Basel). 2024; 14(11).

PMID: 39598258 PMC: 11595495. DOI: 10.3390/life14111460.

A Medical Paradigm Shift in Society 5.0: Implementation of a Smartphone App-based Dry Eye Diagnosis Assistance Software as a Medical Device.

Inomata T, Sung J, Okumura Y, Nagino K, Midorikawa-Inomata A, Eguchi A Juntendo Iji Zasshi. 2024; 70(5):332-338.

PMID: 39545226 PMC: 11560333. DOI: 10.14789/jmj.JMJ24-0018-P.

P4 Medicine for Heterogeneity of Dry Eye: A Mobile Health-based Digital Cohort Study.

Inomata T, Sung J, Yee A, Murakami A, Okumura Y, Nagino K Juntendo Iji Zasshi. 2024; 69(1):2-13.

PMID: 38854846 PMC: 11153075. DOI: 10.14789/jmj.JMJ22-0032-R.

The Influence of Tear Film Quality on Visual Function.

Kastelan S, Gabric K, Mikulicic M, Mrazovac Zimak D, Karabatic M, Gverovic Antunica A Vision (Basel). 2024; 8(1).

PMID: 38535757 PMC: 10974998. DOI: 10.3390/vision8010008.

References

Stapleton F, Alves M, Bunya V, Jalbert I, Lekhanont K, Malet F . TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15(3):334-365. DOI: 10.1016/j.jtos.2017.05.003. View

. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):75-92. DOI: 10.1016/s1542-0124(12)70081-2. View

Hardten D, Brown M, Pham-Vang S . Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease. Curr Med Res Opin. 2007; 23(9):2083-91. DOI: 10.1185/030079907X219670. View

Schaumberg D, Uchino M, Christen W, Semba R, Buring J, Li J . Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction. PLoS One. 2013; 8(9):e76121. PMC: 3786885. DOI: 10.1371/journal.pone.0076121. View

Inomata T, Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y . Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application. Ocul Surf. 2020; 18(2):312-319. DOI: 10.1016/j.jtos.2020.02.007. View

Inomata T, Shiang T, Iwagami M, Sakemi F, Fujimoto K, Okumura Y . Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. Sci Rep. 2018; 8(1):1918. PMC: 5789837. DOI: 10.1038/s41598-018-19775-3. View

Inomata T, Sung J, Fujisawa K, Muto K, Ebihara N, Iwagami M . New medical big data for P4 medicine on allergic conjunctivitis. Allergol Int. 2020; 69(4):510-518. DOI: 10.1016/j.alit.2020.06.001. View

Inomata T, Iwagami M, Hiratsuka Y, Fujimoto K, Okumura Y, Shiang T . Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease. Sci Rep. 2018; 8(1):13443. PMC: 6128834. DOI: 10.1038/s41598-018-31814-7. View

Hyon J, Yang H, Han S . Association between Dry Eye Disease and Psychological Stress among Paramedical Workers in Korea. Sci Rep. 2019; 9(1):3783. PMC: 6405835. DOI: 10.1038/s41598-019-40539-0. View

10.

Johnson M, Murphy P . The Effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements. Cornea. 2005; 24(7):811-7. DOI: 10.1097/01.ico.0000154378.67495.40. View

11.

Vanley G, LEOPOLD I, Gregg T . Interpretation of tear film breakup. Arch Ophthalmol. 1977; 95(3):445-8. DOI: 10.1001/archopht.1977.04450030087010. View

12.

Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K . Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease. BMJ Open. 2019; 9(11):e033940. PMC: 6886996. DOI: 10.1136/bmjopen-2019-033940. View

13.

Tian L, Qu J, Zhang X, Sun X . Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease. J Ophthalmol. 2016; 2016:8013621. PMC: 4844888. DOI: 10.1155/2016/8013621. View

14.

Inomata T, Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K . Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm. Ophthalmology. 2018; 126(5):766-768. DOI: 10.1016/j.ophtha.2018.12.013. View

15.

Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Sung J, Fujimoto K . Stratification of Individual Symptoms of Contact Lens-Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study. J Med Internet Res. 2020; 22(6):e18996. PMC: 7381048. DOI: 10.2196/18996. View

16.

Mengher L, Bron A, Tonge S, Gilbert D . Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res. 1985; 4(1):9-12. DOI: 10.3109/02713688508999961. View

17.

Lemp M . Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995; 21(4):221-32. View

18.

Inomata T, Nakamura M, Iwagami M, Midorikawa-Inomata A, Okumura Y, Fujimoto K . Comparing the Japanese Version of the Ocular Surface Disease Index and Dry Eye-Related Quality-of-Life Score for Dry Eye Symptom Assessment. Diagnostics (Basel). 2020; 10(4). PMC: 7235869. DOI: 10.3390/diagnostics10040203. View

19.

Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E . The challenge of dry eye diagnosis. Clin Ophthalmol. 2009; 2(1):31-55. PMC: 2698717. DOI: 10.2147/opth.s1496. View

20.

van Bijsterveld O . Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969; 82(1):10-4. DOI: 10.1001/archopht.1969.00990020012003. View